Cibus, Inc. engages in the research and development of plant traits to seed companies for royalties. The company is headquartered in San Diego, California. The company went IPO on 2017-07-20. Its business is the development of plant traits for some of the agricultural food crops that help address specific productivity, profitability, sustainability, or yield challenges in farming. Its core technology propriety gene editing platform is called the Rapid Trait Development System (RTDS). The company is the underlying technology in the Company's Trait Machine process, an end-to-end semi-automated high-throughput gene editing system that directly edits seed companies' elite germplasm. The company has a pipeline of five productivity traits. The company has developed the productivity trait Pod Shatter Reduction (PSR) in Canola and Winter Oilseed Rape (WOSR) strengthens the sheath around the canola seeds. Its advanced productivity traits, Sclerotinia resistance and HT2 in Canola and WOSR, continue to progress and offer white mold disease resistance and broadleaf weed herbicide tolerance.
Quelle est la performance du prix de l'action CBUS ?
Le prix actuel de CBUS est de $2.79, il a augmenté de 0.72% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Cibus Inc ?
Cibus Inc appartient à l'industrie Biotechnology et le secteur est Health Care
Quel est la capitalisation boursière de Cibus Inc ?
La capitalisation boursière actuelle de Cibus Inc est de $189.4M
Est-ce que Cibus Inc est un achat, une vente ou un maintien ?
Selon les analystes de Wall Street, 5 analystes ont établi des notations d'analystes pour Cibus Inc, y compris 2 achat fort, 6 achat, 2 maintien, 0 vente et 2 vente forte